Related Experiment Video
Updated: Jun 27, 2026

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
Advance RI-CTR: Advancing a Decade of Discovery for Clinical & Translational Research in Rhode Island
Sharon Rounds1, Edward Hawrot1, Methodius Tuuli1
1Advance RI-CTR, Providence, RI.
Abstract:
Advance Rhode Island Clinical and Translational Research (Advance RI-CTR) is a statewide consortium funded by the Institutional Development Award (IDeA) Program of the National Institute of General Medical Sciences. Over the past decade, it has strengthened Rhode Island's clinical and translational research ecosystem. Led by Brown University in partnership with Brown University Health, Care New England, the Providence VA Medical Center, and the University of Rhode Island, the consortium provides infrastructure, pilot funding, workforce development, and community-engaged resources aligned with state health priorities. Guided by environmental assessment and sustained community input, Advance RI-CTR prioritizes chronic disease and aging, behavioral and mental health, and maternal and child health, with crosscutting emphases on substance use disorder, social determinants of health, and healthcare delivery. Through five integrated cores, the program supports investigators statewide. Major accomplishments include establishing a practice- based research network, expanding informatics capacity, strengthening implementation science, enhancing workforce training, and increasing competitiveness for extramural funding. The program demonstrates strong return on investment and measurable statewide impact.
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Preclinical Development: Overview
Real Time RT-PCR
The real-time quantification of the number of amplified products is...

